基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Despite there has greater understanding of the pathophysiology in idiopathic pulmonary fibrosis,idiopathic pulmonary fibrosis still remains a challenge in clinical practice and translational research due to its heterogeneity.Improvements in molecular techniques have identified potential pathways and targets for diagnosis and therapeutic intervention.Several types of idiopathic pulmonary fibrosis biomarkers such as KL-6,SP-A,SP-D,MMP7 and other potential ones have been studied extensively.In addition,many studies have confirmed that levels of some tumor markers such as CA 19-9,CA 15-3,CEA,CA 125,CYFRA 21-1 are useful for idiopathic pulmonary fibrosis.The present study focuses on serum biomarkers including tumor markers to provide an overview on the current roles of these biomarkers in the setting of diagnosis,prediction as well as response to therapy in idiopathic pulmonary fibrosis.
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Serum biomarkers in evaluation and management of idiopathic pulmonary fibrosis
来源期刊 精准医学研究 学科 医学
关键词 Idiopathic pulmonary fibrosis Biomarkers Serum tumor makers
年,卷(期) 2020,(3) 所属期刊栏目
研究方向 页码范围 127-135
页数 9页 分类号 R56
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2020(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
Idiopathic
pulmonary
fibrosis
Biomarkers
Serum
tumor
makers
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
精准医学研究
季刊
2624-3474
天津市河东区大直沽中路伯苓大厦B座906
出版文献量(篇)
44
总下载数(次)
0
总被引数(次)
0
期刊文献
论文1v1指导